Salvatore A. Del Prete

3.7k total citations
13 papers, 665 citations indexed

About

Salvatore A. Del Prete is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Salvatore A. Del Prete has authored 13 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Salvatore A. Del Prete's work include Ovarian cancer diagnosis and treatment (3 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Salvatore A. Del Prete is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Salvatore A. Del Prete collaborates with scholars based in United States, Belgium and United Kingdom. Salvatore A. Del Prete's co-authors include L. Herbert Maurer, R. Jackson Forcier, George D. Sorenson, Stephen R. Bloom, Mohammed A. Ghatei, Olive S. Pettengill, David P. Ryan, Shekhar Ghamande, Allen Lee Cohn and Stew Kroll and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Salvatore A. Del Prete

13 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salvatore A. Del Prete United States	10	374	307	154	99	99	13	665
Amit J. Sabnis United States	13	245 0.7×	562 1.8×	113 0.7×	125 1.3×	101 1.0×	32	951
Yukinao Kouzu Japan	18	250 0.7×	541 1.8×	189 1.2×	109 1.1×	80 0.8×	28	795
Erin L. Maresh United States	13	277 0.7×	341 1.1×	118 0.8×	241 2.4×	64 0.6×	15	647
Erich Weber Switzerland	10	396 1.1×	418 1.4×	104 0.7×	89 0.9×	174 1.8×	17	757
Markus Grubinger Austria	10	344 0.9×	531 1.7×	214 1.4×	134 1.4×	180 1.8×	12	916
Yvette van Hensbergen Netherlands	12	348 0.9×	301 1.0×	155 1.0×	57 0.6×	129 1.3×	22	666
Yi‐Hung Carol Tan United States	17	255 0.7×	344 1.1×	90 0.6×	200 2.0×	65 0.7×	32	705
Morihiro Higo Japan	18	254 0.7×	584 1.9×	228 1.5×	99 1.0×	99 1.0×	36	841
Andrew N. Stephens Australia	17	342 0.9×	304 1.0×	162 1.1×	81 0.8×	221 2.2×	32	892
Shigeto Hosoe Japan	11	297 0.8×	563 1.8×	168 1.1×	95 1.0×	112 1.1×	19	826

Countries citing papers authored by Salvatore A. Del Prete

Since Specialization

Citations

This map shows the geographic impact of Salvatore A. Del Prete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore A. Del Prete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore A. Del Prete more than expected).

Fields of papers citing papers by Salvatore A. Del Prete

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore A. Del Prete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore A. Del Prete. The network helps show where Salvatore A. Del Prete may publish in the future.

Co-authorship network of co-authors of Salvatore A. Del Prete

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore A. Del Prete. A scholar is included among the top collaborators of Salvatore A. Del Prete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore A. Del Prete. Salvatore A. Del Prete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hsi, David H., Michael I. Ebright, Salvatore A. Del Prete, Gregory D. Pearson, & Michael Bernstein. (2019). A giant left atrial mass—Clinical treatment dilemma. Echocardiography. 36(6). 1200–1202. 1 indexed citations

Marcoux, Nicolas, Scott Gettinger, Grainne M. O’Kane, et al.. (2018). Outcomes of EGFR-mutant lung adenocarcinomas (AC) that transform to small cell lung cancer (SCLC).. Journal of Clinical Oncology. 36(15_suppl). 8573–8573. 1 indexed citations

Goldstein, Lori J., Jayne Gurtler, Salvatore A. Del Prete, et al.. (2014). Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens. Clinical Breast Cancer. 14(6). 396–404. 14 indexed citations

Borad, Mitesh J., Shantan Reddy, Nathan Bahary, et al.. (2014). Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. Journal of Clinical Oncology. 33(13). 1475–1481. 147 indexed citations

Fotopoulou, Christina, Ignace Vergote, Paul N. Mainwaring, et al.. (2013). Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study. Annals of Oncology. 25(1). 160–165. 26 indexed citations

Ng, Kimmie, Josep Tabernero, Jimmy J. Hwang, et al.. (2013). Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens. Clinical Cancer Research. 19(14). 3987–3995. 53 indexed citations

Matulonis, Ursula A., Sudarshan Sharma, Shekhar Ghamande, et al.. (2012). Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. Gynecologic Oncology. 127(1). 63–69. 111 indexed citations

Prete, Salvatore A. Del, et al.. (2009). Breast metastasis from colonic primary: a case report and review of the literature.. PubMed. 73(7). 399–402. 9 indexed citations

Prete, Salvatore A. Del, et al.. (1999). Safety and costs of treating neutropenic fever in an outpatient setting.. PubMed. 63(12). 713–7. 9 indexed citations

10.

Chambers, Setsuko K., Stuart D. Flynn, Salvatore A. Del Prete, Joseph T. Chambers, & Peter E. Schwartz. (1989). Bleomycin, vincristine, mitomycin C and cis-platinum in gynecologic squamous cell carcinomas: A high incidence of pulmonary toxicity. Gynecologic Oncology. 32(3). 303–309. 20 indexed citations

11.

Prete, Salvatore A. Del, et al.. (1984). Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.. PubMed. 68(11). 1403–5. 187 indexed citations

12.

Prete, Salvatore A. Del, L. Herbert Maurer, Truls Brinck‐Johnsen, & George D. Sorenson. (1983). 17-β-estradiol levels in patients with small cell carcinoma of the lung. Journal of Steroid Biochemistry. 18(2). 195–196. 2 indexed citations

13.

Sorenson, George D., et al.. (1982). Bombesin production by human small cell carcinoma of the lung. Regulatory Peptides. 4(2). 59–66. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact